Last 12 months
Inside the activity.
0 purchase rows · 83 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 9 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2024 Filed Mar 18, 2024 22:52 UTC |
Blum Robert IDirector · President & CEO
|
GrantIncentive Stock Option (Right to Buy) · Derivative | 1,568 | $0.00 Strike: $63.75 | $0.00 |
DisclosureSEC source: 0001127602-24-010515 · form4.xml · derivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,568 Underlying: Common Stock · 1,568 shares Expires 2034-03-14 F4 · kind: Award comprised of Non Statutory Stock Options that will vest and become exercisable over 4 years in monthly installments starting April 15, 2024, with the final monthly installment vesting on March 14, 2028. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 22:52 UTC |
Blum Robert IDirector · President & CEO
|
GrantCommon Stock | 61,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-010515 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 461,221 F1 · kind: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an addiitional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:26 UTC |
Wong RobertVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 857 | $66.88 | $57,316.16 |
DisclosureSEC source: 0001127602-24-009017 · form4.xml · nonDerivative · entry 2 Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,585 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:24 UTC |
Malik Fady IbrahamEVP Research & Development
|
Tax withholdingCommon Stock | 8,109 | $66.88 | $542,329.92 |
DisclosureSEC source: 0001127602-24-009016 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,234 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:22 UTC |
Blum Robert IDirector · President & CEO
|
Tax withholdingCommon Stock | 16,725 | $66.88 | $1,118,568.00 |
DisclosureSEC source: 0001127602-24-009013 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,731 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:18 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 5,103 | $66.88 | $341,288.64 |
DisclosureSEC source: 0001127602-24-009010 · form4.xml · nonDerivative · entry 2 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,946 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person. Read SEC document |
| March 05, 2024 Filed Mar 5, 2024 21:05 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 28,604 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-008501 · form4.xml · derivative · entry 4 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,605 Underlying: Common Stock · 28,604 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| March 05, 2024 Filed Mar 5, 2024 21:05 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 28,604 | $67.56 | $1,932,486.24 |
DisclosureSEC source: 0001127602-24-008501 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,973 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| March 05, 2024 Filed Mar 5, 2024 21:05 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 28,604 | $6.67 | $190,788.68 |
DisclosureSEC source: 0001127602-24-008501 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,577 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| March 05, 2024 Filed Mar 5, 2024 21:05 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 4,000 | $67.53 | $270,120.00 |
DisclosureSEC source: 0001127602-24-008501 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,973 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| March 04, 2024 Filed Mar 7, 2024 21:26 UTC |
Wong RobertVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,783 | $67.68 | $120,673.44 |
DisclosureSEC source: 0001127602-24-009017 · form4.xml · nonDerivative · entry 1 Wong Robert · CIK 0001777562 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,442 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person. Read SEC document |
| March 04, 2024 Filed Mar 7, 2024 21:24 UTC |
Malik Fady IbrahamEVP Research & Development
|
Tax withholdingCommon Stock | 9,630 | $67.68 | $651,758.40 |
DisclosureSEC source: 0001127602-24-009016 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,343 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person. Read SEC document |
| March 04, 2024 Filed Mar 7, 2024 21:22 UTC |
Blum Robert IDirector · President & CEO
|
Tax withholdingCommon Stock | 25,341 | $67.68 | $1,715,078.88 |
DisclosureSEC source: 0001127602-24-009013 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 416,456 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person. Read SEC document |
| March 04, 2024 Filed Mar 7, 2024 21:18 UTC |
Callos AndrewEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 2,202 | $67.68 | $149,031.36 |
DisclosureSEC source: 0001127602-24-009010 · form4.xml · nonDerivative · entry 1 Callos Andrew · CIK 0001852129 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,049 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person. Read SEC document |
| February 14, 2024 Filed Feb 14, 2024 21:04 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001127602-24-004994 · form4.xml · derivative · entry 4 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2024-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023. Read SEC document |
| February 14, 2024 Filed Feb 14, 2024 21:04 UTC |
HENDERSON JOHN TDirector
|
SaleCommon Stock | 5,000 | $76.48 | $382,400.00 |
DisclosureSEC source: 0001127602-24-004994 · form4.xml · nonDerivative · entry 3 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,632 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023. Read SEC document |
| February 14, 2024 Filed Feb 14, 2024 21:04 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionCommon Stock | 5,000 | $4.44 | $22,200.00 |
DisclosureSEC source: 0001127602-24-004994 · form4.xml · nonDerivative · entry 2 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023. Read SEC document |
| February 13, 2024 Filed Feb 13, 2024 21:01 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-004668 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,494 Underlying: Common Stock · 12,500 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022. Read SEC document |
| February 13, 2024 Filed Feb 13, 2024 21:01 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 12,500 | $76.85 | $960,625.00 |
DisclosureSEC source: 0001127602-24-004668 · form4.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 441,797 F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022. Read SEC document |
| February 13, 2024 Filed Feb 13, 2024 21:01 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,500 | $6.67 | $83,375.00 |
DisclosureSEC source: 0001127602-24-004668 · form4.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 454,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022. Read SEC document |
| February 06, 2024 Filed Feb 6, 2024 21:43 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 28,605 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-003582 · form4.xml · derivative · entry 4 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,209 Underlying: Common Stock · 28,605 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| February 06, 2024 Filed Feb 6, 2024 21:43 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 4,000 | $79.28 | $317,120.00 |
DisclosureSEC source: 0001127602-24-003582 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,973 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| February 06, 2024 Filed Feb 6, 2024 21:43 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 28,605 | $79.30 | $2,268,376.50 |
DisclosureSEC source: 0001127602-24-003582 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,973 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| February 06, 2024 Filed Feb 6, 2024 21:43 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 28,605 | $6.67 | $190,795.35 |
DisclosureSEC source: 0001127602-24-003582 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:41 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-003154 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,994 Underlying: Common Stock · 12,500 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:41 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 12,500 | $79.57 | $994,625.00 |
DisclosureSEC source: 0001127602-24-003154 · form4.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 441,797 F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:41 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,500 | $6.67 | $83,375.00 |
DisclosureSEC source: 0001127602-24-003154 · form4.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 454,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022. Read SEC document |
| January 19, 2024 Filed Jan 22, 2024 22:19 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-001841 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,494 Underlying: Common Stock · 12,500 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022. Read SEC document |
| January 19, 2024 Filed Jan 22, 2024 22:19 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 12,500 | $81.42 | $1,017,750.00 |
DisclosureSEC source: 0001127602-24-001841 · form4.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 441,797 F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022. Read SEC document |
| January 19, 2024 Filed Jan 22, 2024 22:19 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,500 | $6.67 | $83,375.00 |
DisclosureSEC source: 0001127602-24-001841 · form4.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 454,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022. Read SEC document |
| January 12, 2024 Filed Jan 12, 2024 22:20 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001127602-24-001286 · form4.xml · derivative · entry 4 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2024-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023. Read SEC document |
| January 12, 2024 Filed Jan 12, 2024 22:20 UTC |
HENDERSON JOHN TDirector
|
SaleCommon Stock | 5,000 | $85.14 | $425,700.00 |
DisclosureSEC source: 0001127602-24-001286 · form4.xml · nonDerivative · entry 3 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,632 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023. Read SEC document |
| January 12, 2024 Filed Jan 12, 2024 22:20 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionCommon Stock | 5,000 | $4.44 | $22,200.00 |
DisclosureSEC source: 0001127602-24-001286 · form4.xml · nonDerivative · entry 2 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023. Read SEC document |
| January 04, 2024 Filed Jan 4, 2024 21:36 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 11,678 | $0.00 Strike: $7.96 | $0.00 |
DisclosureSEC source: 0001127602-24-000835 · form4.xml · derivative · entry 4 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,678 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| January 04, 2024 Filed Jan 4, 2024 21:36 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 4,000 | $86.99 | $347,960.00 |
DisclosureSEC source: 0001127602-24-000835 · form4.xml · nonDerivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,973 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| January 04, 2024 Filed Jan 4, 2024 21:36 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 11,678 | $86.98 | $1,015,752.44 |
DisclosureSEC source: 0001127602-24-000835 · form4.xml · nonDerivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,973 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| January 04, 2024 Filed Jan 4, 2024 21:36 UTC |
Malik Fady IbrahamEVP Research & Development
|
Exercise / conversionCommon Stock | 11,678 | $7.96 | $92,956.88 |
DisclosureSEC source: 0001127602-24-000835 · form4.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 162,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023. Read SEC document |
| January 02, 2024 Filed Jan 2, 2024 22:55 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001127602-24-000165 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 155,994 Underlying: Common Stock · 12,500 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022. Read SEC document |
| January 02, 2024 Filed Jan 2, 2024 22:55 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 12,500 | $85.08 | $1,063,500.00 |
DisclosureSEC source: 0001127602-24-000165 · form4.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 441,797 F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022. Read SEC document |
| January 02, 2024 Filed Jan 2, 2024 22:55 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,500 | $6.67 | $83,375.00 |
DisclosureSEC source: 0001127602-24-000165 · form4.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 454,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:29 UTC |
Wysenski NancyDirector
|
GrantCommon Stock | 74 | $84.12 | $6,224.88 |
DisclosureSEC source: 0001127602-24-000441 · form4.xml · nonDerivative · entry 1 Wysenski Nancy · CIK 0001294596 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,156 F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $84.12, representing the Issuer's closing stock price on January 2, 2024. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:27 UTC |
WIERENGA WENDALLDirector
|
GrantCommon Stock | 74 | $84.12 | $6,224.88 |
DisclosureSEC source: 0001127602-24-000433 · form4.xml · nonDerivative · entry 1 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,727 F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $84.12, representing the Issuer's closing stock price on January 2, 2024. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:25 UTC |
SMITH SANDFORD DDirector
|
GrantCommon Stock | 148 | $84.12 | $12,449.76 |
DisclosureSEC source: 0001127602-24-000429 · form4.xml · nonDerivative · entry 1 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,801 F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $84.12, representing the Issuer's closing stock price on January 2, 2024. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:23 UTC |
Kaye Edward M. MDDirector
|
GrantCommon Stock | 148 | $84.12 | $12,449.76 |
DisclosureSEC source: 0001127602-24-000426 · form4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,317 F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $84.12, representing the closing stock price of the Issuer's common stock on January 2, 2024. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:21 UTC |
HENDERSON JOHN TDirector
|
GrantCommon Stock | 252 | $84.12 | $21,198.24 |
DisclosureSEC source: 0001127602-24-000425 · form4.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,632 F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $84.12, representing the closing stock price of the Issuer's common stock on January 2, 2024. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:20 UTC |
Harrington Robert ArthurDirector
|
GrantCommon Stock | 148 | $84.12 | $12,449.76 |
DisclosureSEC source: 0001127602-24-000423 · form4.xml · nonDerivative · entry 1 Harrington Robert Arthur · CIK 0001923988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,521 F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $84.12, representing the closing stock price of the Issuer's common stock on January 2, 2024. Read SEC document |
| December 27, 2023 Filed Dec 27, 2023 21:11 UTC |
WIERENGA WENDALLDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001127602-23-030485 · form4.xml · derivative · entry 6 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2024-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023. F2 · derivative.exercise_date: This option shall vest and become exercisable as to 10,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2015. Read SEC document |
| December 27, 2023 Filed Dec 27, 2023 21:11 UTC |
WIERENGA WENDALLDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001127602-23-030485 · form4.xml · derivative · entry 5 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2024-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023. F2 · derivative.exercise_date: This option shall vest and become exercisable as to 10,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2015. Read SEC document |
| December 27, 2023 Filed Dec 27, 2023 21:11 UTC |
WIERENGA WENDALLDirector
|
SaleCommon Stock | 5,000 | $73.60 | $368,000.00 |
DisclosureSEC source: 0001127602-23-030485 · form4.xml · nonDerivative · entry 4 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,653 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023. Read SEC document |
| December 27, 2023 Filed Dec 27, 2023 21:11 UTC |
WIERENGA WENDALLDirector
|
Exercise / conversionCommon Stock | 5,000 | $4.44 | $22,200.00 |
DisclosureSEC source: 0001127602-23-030485 · form4.xml · nonDerivative · entry 3 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.